Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure

Fig. 4

Clinical course of the second admission. After replacement of the CRT-D generator, the hematoma around the CRT-D recurred and the DIC worsened. DIC improved with the administrate of gabexate mesylate and tranexamic acid. DIC didn’t worsen after switching to oral agents. APTTP, activated partial thromboplastin time; AT3, antithrombin III; CRT-D, cardiac resynchronization therapy-defibrillator; DIC, disseminated intravascular coagulation; FDP, fibrinogen degradation products; PAI-1, plasminogen activator inhibitor-I; PIC, plasmin-α2-plasimin inhibitor complex; PT, prothrombin time; SF, soluble fibrin; TAT, thrombin-antithrombin complex

Back to article page